Hospital Based Cancer Statistics as an Initial Step towards Establishment of Effective Cancer Intervention in Tanzania

Main Article Content

Khamis Othman Amour
Khamza Kibwana Maunda
Peter Kitau Msaki


There is an increasing public awareness that cancer in terms of increasing incidence rates and low curability become a serious problem in Tanzania. Due to limited human and physical resources in Tanzania, cancer interventions that address high incidences, curability and socio-economic impact must be given top priority. This information is often obtained in Population Based Cancer Registry (PBCR) which is not only lacking in Tanzania but its production requires relatively long period of follow-up and high cost of registration. Since establishment of effective cancer intervention is urgent, the desired information needed to accord this priority has been obtained from Hospital Based Cancer Statistics at Ocean Road Cancer Institute (ORCI). From this study, it was found that interventions of cancer of the cervix, breast, kaposi sarcoma, esophageal and head and neck has to be given high priority. It was also observed that treatment outcome for cervical cancer patients of all stages ranged between 34.2 % and 39.1% in the year 2010 and 2015 respectively. Using incidence, curability and socio-economic indices, the cancer type which require effective intervention are cancer of the cervix, breast and kaposi sarcoma. Implicitly, in the low cure rate of each detected cervical cancer in Tanzania compared to high cure rate reported in developed countries, early detection interventions and dose delivery accuracy should be improved.


Download data is not yet available.


Metrics Loading ...

Article Details

How to Cite
Amour, K. O., Maunda, K. K., & Msaki, P. K. (2019). Hospital Based Cancer Statistics as an Initial Step towards Establishment of Effective Cancer Intervention in Tanzania. International Journal for Innovation Education and Research, 7(8), 147-154.
Author Biographies

Khamis Othman Amour, The State University of Zanzibar

Department of Natural and Social Sciences. Assistant Lecturer

Khamza Kibwana Maunda, Ocean Road Cancer Institute United Republic of Tanzania

Department of Oncology, Senior Oncologist

Peter Kitau Msaki, University of Dar es Salaam

Department of Physics, Professor


[1] C. Fitzmaurice, “Burden of cancer in the Eastern Mediterranean Region, 2005–2015: findings from the Global Burden of Disease 2015 Study”, (2017), Int. J. Public Health, 63: 151-164.
[2] L.A. Torre, F. Islami, R.L. Siegel, E.M. Ward and A. Jemal, “Global cancer in women: Burden and trends”, (2017), Cancer Epidemiol Biomarkers, American Association for Cancer Research, Williams Street, Atlanta, , Prev 25(1) January 2016.
[3] J. Ferlay, H.R. Shin, F. Bray, D. Forman, C. Mathers, and D.M. Parkin, 2010, “Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008”, Int. J. Cancer, 127: 2893–2917.
[4] J.Ferley, “Latest world cancer statistics Global cancer burden rises to 14 . 1 million new cases in 2012 : Marked increase in breast cancers must be addressed”, (2013), Int. Agency Res. Cancer, World Heal. Organ, Press rele: 2012–2014.
[5] F. Bray, J. Ferlay, and I. Soerjomataram, “Global Cancer Statistics 2018 : GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries”, (2018), Cancer J cln. 68:394–424.
[6] B. Cao, F. Bray, H. Beltrán-Sánchez, O. Ginsburg, S. Soneji, and I. Soerjomataram, “Benchmarking life expectancy and cancer mortality: global comparison with cardiovascular disease 1981-2010”, (2017), Bmj 357: j2765.
[7] K.K. Poudel, Z. Huang , P.R. Neupane, R. Steel, and J.K. Poudel, “Hospital-Based Cancer Incidence in Nepal from 2010 to 2013 Abstract”,(2013), Nepal J. Epidemiol, NepJOL-INASP, 7: 659–665.
[8] J.Chen , H. Chen , J. Zhu, Y.Yang, Y. Zhang, and P. Huang, 2018 “Cancer survival in patients from a hospital-based cancer registry”, (2018), China. J. cancer , 9.
[9] T. Matsuda, and K. Saika, “Cancer burden in Japan based on the latest cancer statistics : need for evidence-based cancer control programs”, (2018), Ann Cancer Epidemiol, 2:2.
[10] T. Ngoma, R. Muwonge, J. Mwaiselage, J. Kawegere, P. Bukori, and R. Sankaranarayanan, “Evaluation of cervical visual inspection screening in Dar es Salaam, Tanzania”, Int J Gynaecol Obs, Elsevier Ireland Ltd, (2010), 109: 100–104.
[11] T. Ngoma, C. Kahesa, and J. Mwaiselage, “Cost-Effectiveness of Screening and Treatment for Cervical Cancer in Tanzania: Implications for other Sub-Saharan African Countries”, (2016), Value Health Reg, 10: 1–6.
[12] H.L. Kidanto, C.D. Kilewo, and C. Moshiro, “Cancer of the Cervix: Knowledge and Attitudes of Female Patients Admitted At Muhimbili National Hospital, Dar es Salaam”, (2002), East African Med. J, 79: 467–475.
[13] R. McCree, M.R. Giattas, V.V. Sahasrabuddhe, P.E. Jolly, M.Y. Martin, S.L. Usdan , C. Kohler, and N. Lisovicz, “Expanding Cervical Cancer Screening and Treatment in Tanzania: Stakeholders’ Perceptions of Structural Influences on Scale-Up”, (2015) Oncologist, 20: 621–6.
[14] E. Cazap, I. Magrath, T.P. Kingham, and A. Elzawawy, “Structural barriers to diagnosis and treatment of cancer in low- and middle-income countries: The urgent need for scaling up”, (2016), J. Clin. Oncol, 34: 14–19.
[15] F.I. Modibbo , E. Dareng, P. Bamisaye, E. Jedy-Agba, A. Adewole, L. Oyeneyin , O. Olaniyan, and C. Adebamowo , “Qualitative study of barriers to cervical cancer screening among Nigerian women”, (2016), BMJ Open, 6: e008533.